Table 5.
STEMI | NSTEMI | |||
---|---|---|---|---|
Diabetic | Non-diabetic | Diabetic | Non-diabetic | |
Statistical optimal SHR cut-off in mmol/L | 1.68 | 1.51 | 1.53 | 1.27 |
Sensitivity in % (95% CI) | 50.4 (44.1–56.7) | 55.0 (47.8–61.9) | 35.4 (28.0–43.3) | 44.6 (31.3–58.5) |
Specificity in % (95% CI) | 83.2 (81.7–84.6) | 82.2 (80.7–83.6) | 78.3 (76.5–80.0) | 79.0 (77.0–80.9) |
Positive predictive value in % (95% CI) | 22.7 (20.2–25.5) | 18.1 (16.0–20.4) | 10.8 (8.8–13.1) | 6.5 (4.9–8.6) |
Negative predictive value in % (95% CI) | 94.5 (93.8–95.1) | 96.2 (95.6–96.7) | 94.2 (93.6–94.9) | 97.8 (97.2–98.2) |
CI confidence interval, SHR stress-hyperglycaemia ratio, NSTEMI non-ST-segment elevation myocardial infarction, STEMI ST-segment elevation myocardial infarction